Features August 2003 Issue

Popular Arthritis Drugs Less Cost-Effective Than Common Pain Killers

Selective COX-2 inhibitors, such as rofecoxib (Vioxx) and celecoxib (Celebrex), are not as cost-effective as common non-steroidal anti-inflammatory drugs, such as ibuprofen (Motrin, Advil, Nuprin), indomethacin, and naproxen, in treating arthritis in the average patient.

This was the conclusion of a recent study conducted by the University of California (Los Angeles) and the Veterans Affairs of Greater Los Angeles. Researchers found that the newer COX-2 drugs, developed to offer the same pain relief as NSAIDs butů

To continue reading this article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.